LRRK2 deficiency mitigates amyloid β deposition-mediated pathology in a murine Alzheimer’s disease model by reprogramming microglia

🥉 Top 5% JournalOct 6, 2025Translational psychiatry

LRRK2 deficiency may reduce amyloid beta-related damage in a mouse Alzheimer's model by changing immune brain cells

AI simplified

Abstract

5xFAD; mice showed significant improvements in cognitive function and reduced Aβ plaque accumulation compared to .

5xFAD;LRRK2 mice exhibited enhanced learning and memory abilities.
Cerebral and hippocampal Aβ plaque burden was reduced in 5xFAD;LRRK2 mice.
Decreased microglia and astrocyte presence was observed in the hippocampus of 5xFAD;LRRK2 mice.
A decline in proinflammatory cytokines suggests changes in microglial activity.
LRRK2 absence prevented synaptic loss and balanced excitatory and inhibitory synapses.
5xFAD;LRRK2 mice showed increased microglial phagocytosis, leading to lower Aβ aggregation.

AI simplified

Leucine-rich repeat kinase 2 (), primarily expressed in microglia, is responsible for the modulation of innate immune responses and associated with various immunological disorders. Available evidence documents that though as the predominant etiological factor for familial Parkinson's disease, LRRK2 mutations rarely occur in Alzheimer's disease (AD) and that LRRK2 polymorphism is potentially associated with late-onset AD. However, the role of LRRK2 in AD immunopathogenesis remains unknown. In this study, we investigated the impact of LRRK2 deficiency on cognitive function, Aβ plaque accumulation, and plaque-associated neuropathology in AD mice. The results revealed that compared with the , the 8-month-old 5xFAD;LRRK2mice reported improved learning and memory, reduced cerebral and hippocampal Aβ plaque burden, and decreased microglia and astrocytes within the central region of hippocampal Aβ plaques. The 5xFAD;LRRK2mice also showed a decrease in several complement and proinflammatory cytokines in the brain, indicating an altered microglial phenotype. Furthermore, the absence of LRRK2 prevented synaptic loss and restored the disrupted equilibrium between excitatory and inhibitory synapses in the 5xFAD mice. These findings suggest that LRRK2 may play an essential role in Aβ plaque pathology, glial responses to plaques, and neuronal dysfunction in the brain of the 5xFAD mice and that a genomic transgene-blockade of LRRK2 may reprogram the microglial responsivity, thus mitigating the neuropathological and behavioral deficits in AD mice. The 5xFAD;LRRK2mice reduced cognitive impairment in the Morris water maze test compared with the 5xFAD mice. The protective effect of LRRK2 inhibition is not dependent on the APP production process or Aβ degradation. Conversely, 5xFAD;LRRK2mice enhanced microglial phagocytosis, reducing Aβ aggregation and glial activation. Additionally, compared with the 5xFAD, the 5xFAD;LRRK2mice exhibited preserved synaptic structure, characterized by higher PSD95 expression, lower C1qa/C3 expression in both excitatory and inhibitory synapses, upregulated VGLUT1 expression, and downregulated VGAT expression. -/--/--/--/--/-

Key numbers

14 of 17

Cognitive Improvement

Mice showing improved performance in the Morris water maze test.

5 of 5

Plaque Reduction

Mice with deficiency exhibited reduced amyloid β plaques.

Full Text

We can’t show the full text here under this license. Use the link below to read it at the source.

View full text (PDF) ↗View full text (HTML) ↗View full text (PDF) ↗

Abstract

Key numbers

Full Text

Related papers